Boston CEO
Date: Location: Cost:
May 30 - 31, 2017 Four Seasons Boston
200 Boylston Street
Boston, MA 02116
(617) 338-4400

Starting at $1950

 

Dress Code:
Business Attire

Register

Boston CEO - May 30, 2017

Co-hosts: Paul Biondi, Robert Coughlin, Deborah Dunsire, Mike Ehlers, JC Gutierrez-Ramos, Ed Kaye, John Maraganore, David Meek, Paris Panayiotopoulos, Rob Perez, Roger Pomerantz, Ronald Renaud, Al Sandrock, Paula Soteropoulos, Henri Termeer, Roger Tung, Sue Washer, Christoph Westphal

Time Agenda
7:30-8:30 am

Registration and Networking Breakfast

8:30-8:40 am

Welcome and Opening Remarks

8:40-9:00 am

Fireside Chat
Henri Termeer
, former CEO, Genzyme
Moderator: Christoph WestphalCo-Founder & Partner, Longwood Fund

9:00-9:30 am

CEO Roundtable
Deborah Dunsire, CEO, XTuit Pharmaceuticals; Rob Perez, Founder & Chairman, Life Science Cares; Henri Termeer, former CEO, Genzyme

9:30-10:00 am

Healthcare Market Outlook -- 2017 and Beyond
Robert Guidos, Associate Director, Legislative Affairs, FDA; Alfred ScheideggerFounding Partner & CEONextech Invest; Gary Zieziula, President & Managing Director, EMD Serono
Moderator: Michael Goettler, Global President, Rare Diseases, Pfizer

10:00-10:30 am

Networking Break

10:30-11:00 am

Understanding and Managing Growth
Mary Lynne HedleyCo-founder, President & COO, TESARO; William Heiden, CEO, AMAG Pharmaceuticals; Shalini Sharp, CFO, Ultragenyx
Moderator: Robert Beardsley, COO, Galera Therapeutics

11:00-11:30 am

Diversity: Moving from Sound Bite to Implementation
Jeff Albers, CEO, Blueprint Medicines; Suzanne Bruhn, Board, Aeglea BioTherapeutics; Andi Keriboutis, former EVP, Biogen; Martin Mackay, EVP, Head, R&D, Alexion
Moderator: Cissy Young, Executive Director, Russell Reynolds

11:30-12:00 pm

Ensuring Transparency and Drug Value
Ron Cooper, President & CEO, Albireo; Thomas Lönngrenformer Executive Director, European Medicines Agency (EMA); Ed Mascioli, CEO, Karos Pharmaceuticals

12:00-1:00 pm

Networking Lunch

1:00-1:30 pm

Evolving BioPharma Boards
Don deBethizy
, Chairman, Albumedix A/S

1:30-2:00 pm

Accessing Early-Stage Innovation
Ansbert Gadicke, Co-Founder & Managing Director, MPM Capital; Adi Hoess, CEO, Affimed; Bernard DavitianVP & Managing Director, Sanofi-Genzyme BioVentures; Chandra Ramanathan, VP & Head, East Coast Innovation Center, Bayer

2:00-2:30 pm

Therapeutic Market Focus: Microbiome
Mark Bodmer
, CSO & President of R&D, Evelo Biosciences; Todd Krueger, President, AOBiome; Bernat Olle, CEO, Vedanta Biosciences; Jeff Riley, CEO, Synthetic Biologics

2:30-3:00 pm

Networking Break

3:00-3:30 pm

Oncology Trends and Predictions
Gil Beyen, Chairman & CEO, Erytech; Arthur Krieg, CEO, Checkmate Pharmaceuticals; Oliver Rosen, CMO, Deciphera; Patrick TricoliCEO, Nanobiotix US
Moderator: Jeremy Goldberg, Managing Director, Torreya Partners

3:30-4:00 pm

Building a Biotech: Innovative Business Models
Yuval Cohen, CEO, Corbus Pharmaceuticals; Ana Maiques, CEO, Neuroelectrics; Eddie Martucci, Co-Founder & CEO, Akili Interactive; Paula Soteropoulos, CEO, Akcea Therapeutics; Gregory Verdine, Founder, CEO, & CSO, FogPharma
Moderator: JC Gutierrez-RamosCEO, Synlogic Therapeutics

4:00-4:30 pm

Partner or Go it Alone?
Carl Firth, CEO, Aslan Pharmaceuticals; Kia MoteshareiVP & Global Head, BD, Neurology & Immunology, EMD Serono; Tim Noyes, President & CEO, Proteon Therapeutics; Leslie Williams, Founder, President & CEO, ImmusanT
Moderator: Michael Bell, Chairman & CEO, inVentiv Health

4:30-5:10 pm

Next Generation Biotech CEOs and Board Members
Francois Nader, Chairman, Acceleron Pharma; Rob Perez, Partner, Vineyard Sound Advisors

5:10-6:00 pm

Cocktails & Hors d'oeuvres

May 31, 2017

Co-hosts: Paul Biondi, Robert Coughlin, Deborah Dunsire, Mike Ehlers, JC Gutierrez-Ramos, Ed Kaye, John Maraganore, David Meek, Paris Panayiotopoulos, Rob Perez, Roger Pomerantz, Ronald Renaud, Al Sandrock, Paula Soteropoulos, Henri Termeer, Roger Tung, Sue Washer, Christoph Westphal

Time Agenda
7:30-8:30 am

Registration and Networking Breakfast

8:30-8:40 am

Welcome and Opening Remarks

8:40-9:10 am

Advances in Personalized Medicine
Arthur Hiller, CEO, Antyllus; Kenneth Moch, President & CEO, Cognition Therapeutics; Joe Payne, President & CEO, Arcturus; Steven Perrin, CEO & CSO, ALS Therapy Development Institute; Al Sandrock, CMO & EVP, Biogen
Moderator: Robert Silverman, Head, Externalized Drug Discovery PartneringRoche

9:10-9:40 am

Small-Cap and Private Biotech: Leveraging Potential
Gregg Beloff
, CFO, Centrexion Therapeutics; Brian Leuthner, President & CEO, Edge Therapeutics; Dan Swisher, CEO, Sunesis Pharmaceuticals; Ailis Tweed-Kent, Founder & CEO, Cocoon Biotech

9:40-10:10 am

Therapeutic Market Focus: Cell & Gene Therapy
Ed Kaye
, CEO & CMO, Sarepta

10:10-10:40 am

Networking Break

10:40-11:00 am

Fireside Chat
Michael Ehlers
EVP, R&D, Biogen; David Meek, CEO, IPSEN
Moderator: Christoph WestphalCo-Founder & Partner, Longwood Fund

11:00-11:30 am

Accessing Innovation via M&A and Partnerships
Chris Christoffersen, Partner, Lightstone Ventures; Sven Dethlefs, Global Head Respiratory Medicines, Teva; Lisa McKerracher, Founder & CEO, BioAxone BioSciences; Cynthia Schwalm, President, North America Commercial Operations, IPSEN
Moderator: Sue WasherPresident & CEO, AGTC

11:30-12:00 pm

Buy or Build?
Grace Colon, CEO, InCarda Therapeutics; Michael Ehlers, EVP, R&D, Biogen; Roger Tung, CEO, Concert Pharmaceuticals
Moderator: Steve Cutler, CEO, ICON

12:00-1:00 pm

Networking Lunch

1:00-1:30 pm

Moderated Keynote
Governor Charlie Baker, Commonwealth of Massachusetts
Moderator: Christoph WestphalCo-Founder & Partner, Longwood Fund

1:30-2:00 pm

Boston-Bound Biotech and Pharma: Impact on Innovation
Paul Bolno, President & CEO, WaVe Life Sciences; Jonathan Lewis, CEO, Samus Therapeutics
Moderator: Bob Coughlin, President & CEOMassBio

2:00-2:30 pm

Global Markets: Biotechs Across Borders
Samatha Du
, Chairperson & CEO, Zai Laboratory; Mary Szela, CEO, Novelion Therapeutics

2:30-3:00 pm

Networking Break

3:00-3:20 pm

Fireside Chat
John Maraganore
, CEO, Alnylam
Moderator: Christoph WestphalCo-Founder & Partner, Longwood Fund

3:20-3:50 pm

Achieving Organizational Turnarounds
Richard Daly
, Chairman & CEO, Neuralstem
Moderator: Paris Panayiotopoulos, President & CEO, ARIAD Pharmaceuticals

3:50-4:20 pm

M&A Activity Post the IPO-Boom: Impact on Fundraising and Dealmaking
John HaurumCEO, F-star Biotechnology; Philippe Lopes-Fernandes, SVP, Global Head, BD & Alliance ManagementEMD Serono

4:20-4:45 pm

Presentation of 2016 Boston CEO Lifetime Achievement Award
Bob Coughlin, 2016 Honoree; John Maraganore, 2015 Honoree

4:45-6:00 pm

Cocktails & Hors d'oeuvres

Premier Sponsors: (see all sponsors)

<